GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status
Link T, Blohmer JU, Just M, Untch M, Stoetzer O, Fasching P, Schneeweiss A, Wimberger P, Seiler S, Huober J, Schmitt WD, Jackisch C, Rhiem KE, Hanusch C, Denkert C, Sinn BV, Engels K, Nekljudova V, Loibl S (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S308-S309
Conference Proceedings Title: ANNALS OF ONCOLOGY
Event location: , ELECTR NETWORK
DOI: 10.1016/j.annonc.2020.08.290
Authors with CRIS profile
Involved external institutions
Universitätsklinikum Heidelberg
Germany (DE)
Onkologische Schwerpunktpraxis Bielefeld
Germany (DE)
HELIOS Kliniken
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Universitätsklinikum Köln
Germany (DE)
Rotkreuzklinikum München
Germany (DE)
Technische Universität Dresden
Germany (DE)
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss
Germany (DE)
Universitätsklinikum Gießen und Marburg (UKGM)
Germany (DE)
Sana Klinikum Offenbach
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Germany (DE)
Onkologische Schwerpunktpraxis Bielefeld
Germany (DE)
HELIOS Kliniken
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Universitätsklinikum Köln
Germany (DE)
Rotkreuzklinikum München
Germany (DE)
Technische Universität Dresden
Germany (DE)
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss
Germany (DE)
Universitätsklinikum Gießen und Marburg (UKGM)
Germany (DE)
Sana Klinikum Offenbach
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
How to cite
APA:
Link, T., Blohmer, J.-U., Just, M., Untch, M., Stoetzer, O., Fasching, P.,... Loibl, S. (2020). GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status. In ANNALS OF ONCOLOGY (pp. S308-S309). , ELECTR NETWORK: AMSTERDAM: ELSEVIER.
MLA:
Link, T., et al. "GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status." Proceedings of the ESMO Virtual Congress, , ELECTR NETWORK AMSTERDAM: ELSEVIER, 2020. S308-S309.
BibTeX: Download